SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome

Here we show that surface-enhanced Raman scattering (SERS) analysis captures the relative hypomethylation of DNA from patients with acute leukemia associated with Down syndrome (AL-DS) compared with patients diagnosed with transient leukemia associated with Down syndrome (TL-DS), an information infe...

Full description

Bibliographic Details
Main Authors: Vlad Moisoiu, Valentina Sas, Andrei Stefancu, Stefania D. Iancu, Ancuta Jurj, Sergiu Pasca, Sabina Iluta, Alina-Andreea Zimta, Adrian B. Tigu, Patric Teodorescu, Cristina Turcas, Cristina Blag, Delia Dima, Gheorghe Popa, Smaranda Arghirescu, Sorin Man, Anca Colita, Nicolae Leopold, Ciprian Tomuleasa
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.703268/full
_version_ 1818671384723718144
author Vlad Moisoiu
Valentina Sas
Valentina Sas
Andrei Stefancu
Stefania D. Iancu
Ancuta Jurj
Sergiu Pasca
Sabina Iluta
Alina-Andreea Zimta
Adrian B. Tigu
Patric Teodorescu
Cristina Turcas
Cristina Blag
Delia Dima
Gheorghe Popa
Smaranda Arghirescu
Smaranda Arghirescu
Sorin Man
Anca Colita
Anca Colita
Nicolae Leopold
Nicolae Leopold
Ciprian Tomuleasa
Ciprian Tomuleasa
Ciprian Tomuleasa
author_facet Vlad Moisoiu
Valentina Sas
Valentina Sas
Andrei Stefancu
Stefania D. Iancu
Ancuta Jurj
Sergiu Pasca
Sabina Iluta
Alina-Andreea Zimta
Adrian B. Tigu
Patric Teodorescu
Cristina Turcas
Cristina Blag
Delia Dima
Gheorghe Popa
Smaranda Arghirescu
Smaranda Arghirescu
Sorin Man
Anca Colita
Anca Colita
Nicolae Leopold
Nicolae Leopold
Ciprian Tomuleasa
Ciprian Tomuleasa
Ciprian Tomuleasa
author_sort Vlad Moisoiu
collection DOAJ
description Here we show that surface-enhanced Raman scattering (SERS) analysis captures the relative hypomethylation of DNA from patients with acute leukemia associated with Down syndrome (AL-DS) compared with patients diagnosed with transient leukemia associated with Down syndrome (TL-DS), an information inferred from the area under the SERS band at 1005 cm–1 attributed to 5-methycytosine. The receiver operating characteristic (ROC) analysis of the area under the SERS band at 1005 cm–1 yielded an area under the curve (AUC) of 0.77 in differentiating between the AL-DS and TL-DS groups. In addition, we showed that DNA from patients with non-DS myeloproliferative neoplasm (non-DS-MPN) is hypomethylated compared to non-DS-AL, the area under the SERS band at 1005 cm–1 yielding an AUC of 0.78 in separating between non-DS-MPN and non-DS-AL. Overall, in this study, the area of the 1005 cm–1 DNA SERS marker band shows a stepwise decrease in DNA global methylation as cells progress from a pre-leukemia to a full-blown acute leukemia, highlighting thus the potential of SERS as an emerging method of analyzing the methylation landscape of DNA in the context of leukemia genesis and progression.
first_indexed 2024-12-17T07:23:09Z
format Article
id doaj.art-022013ee427e44ee9a23ad0c7a0b27bb
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-12-17T07:23:09Z
publishDate 2021-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-022013ee427e44ee9a23ad0c7a0b27bb2022-12-21T21:58:41ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852021-07-01910.3389/fbioe.2021.703268703268SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down SyndromeVlad Moisoiu0Valentina Sas1Valentina Sas2Andrei Stefancu3Stefania D. Iancu4Ancuta Jurj5Sergiu Pasca6Sabina Iluta7Alina-Andreea Zimta8Adrian B. Tigu9Patric Teodorescu10Cristina Turcas11Cristina Blag12Delia Dima13Gheorghe Popa14Smaranda Arghirescu15Smaranda Arghirescu16Sorin Man17Anca Colita18Anca Colita19Nicolae Leopold20Nicolae Leopold21Ciprian Tomuleasa22Ciprian Tomuleasa23Ciprian Tomuleasa24Faculty of Physics, Babeş-Bolyai University, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaFaculty of Physics, Babeş-Bolyai University, Cluj-Napoca, RomaniaFaculty of Physics, Babeş-Bolyai University, Cluj-Napoca, RomaniaResearch Center for Functional Genomics and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaMedfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaMedfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Pediatrics, Victor Babeş University of Medicine and Pharmacy, Timisoara, RomaniaDepartment of Pediatrics, Louis Turcanu Emergency Hospital for Children, Timisoara, RomaniaDepartment of Pediatrics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaDepartment of Pediatrics, Carol Davila University of Medicine and Pharmacy, Bucharest, RomaniaDepartment of Pediatrics, Fundeni Clinical Institute, Bucharest, RomaniaFaculty of Physics, Babeş-Bolyai University, Cluj-Napoca, Romania0Biomed Data Analytics SRL, Cluj-Napoca, RomaniaDepartment of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, RomaniaMedfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania1Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj-Napoca, RomaniaHere we show that surface-enhanced Raman scattering (SERS) analysis captures the relative hypomethylation of DNA from patients with acute leukemia associated with Down syndrome (AL-DS) compared with patients diagnosed with transient leukemia associated with Down syndrome (TL-DS), an information inferred from the area under the SERS band at 1005 cm–1 attributed to 5-methycytosine. The receiver operating characteristic (ROC) analysis of the area under the SERS band at 1005 cm–1 yielded an area under the curve (AUC) of 0.77 in differentiating between the AL-DS and TL-DS groups. In addition, we showed that DNA from patients with non-DS myeloproliferative neoplasm (non-DS-MPN) is hypomethylated compared to non-DS-AL, the area under the SERS band at 1005 cm–1 yielding an AUC of 0.78 in separating between non-DS-MPN and non-DS-AL. Overall, in this study, the area of the 1005 cm–1 DNA SERS marker band shows a stepwise decrease in DNA global methylation as cells progress from a pre-leukemia to a full-blown acute leukemia, highlighting thus the potential of SERS as an emerging method of analyzing the methylation landscape of DNA in the context of leukemia genesis and progression.https://www.frontiersin.org/articles/10.3389/fbioe.2021.703268/fullSERSdown syndromeacute leukemiatransient leukemia associated with down syndromemyeloproliferative neoplasm
spellingShingle Vlad Moisoiu
Valentina Sas
Valentina Sas
Andrei Stefancu
Stefania D. Iancu
Ancuta Jurj
Sergiu Pasca
Sabina Iluta
Alina-Andreea Zimta
Adrian B. Tigu
Patric Teodorescu
Cristina Turcas
Cristina Blag
Delia Dima
Gheorghe Popa
Smaranda Arghirescu
Smaranda Arghirescu
Sorin Man
Anca Colita
Anca Colita
Nicolae Leopold
Nicolae Leopold
Ciprian Tomuleasa
Ciprian Tomuleasa
Ciprian Tomuleasa
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
Frontiers in Bioengineering and Biotechnology
SERS
down syndrome
acute leukemia
transient leukemia associated with down syndrome
myeloproliferative neoplasm
title SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
title_full SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
title_fullStr SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
title_full_unstemmed SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
title_short SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
title_sort sers based evaluation of the dna methylation pattern associated with progression in clonal leukemogenesis of down syndrome
topic SERS
down syndrome
acute leukemia
transient leukemia associated with down syndrome
myeloproliferative neoplasm
url https://www.frontiersin.org/articles/10.3389/fbioe.2021.703268/full
work_keys_str_mv AT vladmoisoiu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT valentinasas sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT valentinasas sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT andreistefancu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT stefaniadiancu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT ancutajurj sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT sergiupasca sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT sabinailuta sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT alinaandreeazimta sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT adrianbtigu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT patricteodorescu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT cristinaturcas sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT cristinablag sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT deliadima sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT gheorghepopa sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT smarandaarghirescu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT smarandaarghirescu sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT sorinman sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT ancacolita sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT ancacolita sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT nicolaeleopold sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT nicolaeleopold sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT cipriantomuleasa sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT cipriantomuleasa sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome
AT cipriantomuleasa sersbasedevaluationofthednamethylationpatternassociatedwithprogressioninclonalleukemogenesisofdownsyndrome